#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Waldenstrom's macroglobulinaemia recurrent Bronchopulmonary dysplasia Antisynthetase syndrome Acute hepatic failure Cerebellar ataxia Antiphospholipid antibodies Deafness Macular telangiectasia Leiomyosarcoma X-linked lymphoproliferative syndrome Vulval cancer recurrent Neuropathy peripheral Congenital growth hormone deficiency Arterial tortuosity syndrome Follicle centre lymphoma follicular grade I II – III refractory More trials…

    Learn about Rare Diseases

    Netherton’s syndrome – Diagnostics Haemophilia B with anti factor IX – Treatment Haemophagocytic lymphohistiocytosis – Diagnostics Sarcoidosis – Basic Information Mucous membrane pemphigoid – Life with Disease Leiomyosarcoma metastatic Ehlers-Danlos syndrome – Diagnostics Lysosomal storage disorder – Basic Information Mantle cell lymphoma stage II – Trials in Disease Marginal zone lymphoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clozapine Metamizole Crisantaspase Atorvastatin Calcium Calcium Chloride Betaine Citrate Ampicillin Pbf-999 Radium Ra 223 Dichloride NALMEFENE HYDROCHLORIDE Milrinone Perindopril Arginine Lorazepam Caffeine Patiromer Lepidoglyphus Destructor Sulfamethizole Sar-443579 Keto-Valine Calcium Sulfamethoxazole More therapies…

    Learn about Your Condition

    Mantle cell lymphoma recurrent Appendicitis Mantle cell lymphoma Primary hyperthyroidism Dedifferentiated liposarcoma Synovitis Bronchiectasis Pulmonary tuberculosis Dyslipidaemia Chronic hepatitis B Uveitis Bronchiolitis Vasoplegia syndrome Electronic cigarette user Oesophagectomy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Seasonal allergy

  • Study on the Effectiveness and Safety of a Grass and Juniperus Oxycedrus Allergy Vaccine for Patients with Allergic Rhinitis or Rhinoconjunctivitis with or without Mild Asthma

    Recruiting

    3 1
    Investigated Diseases:
    • Conjunctivitis allergic
    • Rhinitis allergic
    • Seasonal allergy
    Investigated Drugs:
    • Allergen Extract From Dactylis Glomerata Pollen, Glutaraldehyde-Modified
    • Allergen Extract From Lolium Perenne Pollen, Glutaraldehyde-Modified
    • Allergen Extract From Phleum Pratense Pollen, Glutaraldehyde-Modified
    Spain

  • Short‑course sublingual ITULAZAX birch pollen extract with Lactobacillus rhamnosus GG for patients with pollen‑associated food allergy

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Betula Verrucosa (108)
    Germany

  • Dose-finding study of sublingual immunotherapy with phleum pratense extract (vs sodium chloride) in patients with grass pollen allergic rhinitis

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Seasonal allergy
    Investigated Drugs:
    • Phleum Pratense
    • Sodium Chloride
    Spain

  • Study to Find the Best Dose of Beltavac with Grass Pollen Extract for Patients with Allergic Rhinoconjunctivitis, with or without Asthma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Seasonal allergy
    Investigated Drugs:
    • Allergenic Extract Of Grass Pollen Mixture: Dactylis Glomerata, Festuca Pratensis, Lolium Perenne, Phleum Pratense And Poa Pratensis (1:1:1:1:1), Polymerised
    • Placebo
    Poland Spain

  • Study on the Effectiveness of Beltavac with Grass Pollen Extract for Patients with Allergic Rhinoconjunctivitis and Possible Asthma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Seasonal allergy
    Investigated Drugs:
    • Allergenic Extract Of Grass Pollen Mixture: Dactylis Glomerata, Festuca Pratensis, Lolium Perenne, Phleum Pratense And Poa Pratensis (1:1:1:1:1), Polymerised
    • Placebo
    Poland Spain

  • Study of CLU-RX-PHL injection therapy for patients with moderate to severe grass pollen allergy to find the most effective and safe dose

    Not recruiting

    4 1
    Investigated Diseases:
    • Conjunctivitis allergic
    • Seasonal allergy
    Investigated Drugs:
    • Allergen Extract From Phleum Pratense Pollen, Glutaraldehyde-Modified
    Germany
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!